Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-07-06

FDA Approved: NATEGLINIDE — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved Zydus Lifesciences Limited's original application for nateglinide, a meglitinide insulin secretagogue, for the treatment of type 2 diabetes mellitu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nateglinide (nateglinide)

Snippet

ORIG AP for NATEGLINIDE (NATEGLINIDE)